2169336
Last Update Posted: 2015-12-10
Recruiting has ended
All Genders accepted | 18 Years-70 Years |
95 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
The primary objective of this study is to evaluate the analgesic efficacy of two dose levels of DEX-IN compared with placebo, using the summed pain intensity difference over the first 48 hours (SPID48) in subjects with acute moderate to severe pain following unilateral bunionectomy.
Eligibility
Relevant conditions:
Pain, Post-operative
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov